Selvita is a preclinical CRO offering multidisciplinary support within the areas of drug discovery and drug development. 

The company offers drug discovery support from early discovery phase up to the preclinical development. Selvita specializes in in silico drug design, SAR and ADME-driven lead optimization, toxicity prediction, followed by complex pharmacology and structural biology. Selvita has broad expertise and track record in oncology, inflammation, fibrosis, anti-infectives, respiratory diseases and CNS.

What's more, the company provides analytical support for drug development, including drug product development, small pilot plant capabilities, formulation, process development competencies, and microbiological testing, ensuring seamless progression through the drug development pipeline.